Yüklüyor......

Management of acquired resistance to EGFR kinase inhibitors in advanced NSCLC

The widespread adoption of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the first-line treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC) has resulted in acquired TKI resistance becoming a ubiquitous clinical problem. The identification of specific...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sacher, Adrian G., Jänne, Pasi A., Oxnard, Geoffrey R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117471/
https://ncbi.nlm.nih.gov/pubmed/24752335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28723
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!